Most chronic fatigue, metabolic inflexibility, and slow recovery trace back to the same root cause: mitochondria that can't produce enough ATP. The Mito Stack addresses this at three levels — SS-31 repairs the physical membrane structure, MOTS-c retrains metabolic signaling to build new mitochondria, and NAD+ restores the redox currency both processes consume.
The practical case is strongest for two populations:
- Those experiencing GLP-1 fatigue (where rapid caloric deficit from semaglutide, tirzepatide, or retatrutide strains mitochondrial capacity)
- Individuals with chronic energy depletion from illness, overtraining, or age-related decline.
The protocol runs in 12-week cycles — SS-31 loads first to repair membrane integrity (with NAD+ layered in as support), then MOTS-c is added in to build capacity on a repaired foundation.
At a Glance
| Component | Core role |
|---|---|
| SS-31 | Repairs mitochondrial membranes, reducing electron leak and oxidative damage |
| MOTS-c | Retrains metabolic signaling — improves fuel flexibility and builds new mitochondria |
| NAD+ | Restores the redox currency cells need for energy production, DNA repair, and longevity enzymes |
| Protocol cadence | 12-week cycles with loading and maintenance phases |
| Complementary | L-Carnitine injectable for fatty acid transport; 5-Amino-1MQ for NAD+ preservation in adipose tissue |
| Primary applications | Fatigue, metabolic dysfunction, injury recovery support, and longevity support |
What Is a Mitochondrial Peptide Stack?
This stack combines three compounds that target different aspects of mitochondrial function — addressing structure (SS-31), signaling (MOTS-c), and fuel (NAD+) simultaneously. These are the three axes that determine whether your mitochondria produce abundant energy or limp along in survival mode.
MOTS-c is your body's own exercise signal — a peptide that mitochondria release during physical stress to reprogram how cells use energy. It mimics what happens when you train hard, even when you don't. SS-31 protects the membrane where energy production actually happens — the part that degrades with age and oxidative damage. NAD+ is the fuel both processes run on, and it declines measurably as you age.
Each addresses a different failure point. MOTS-c tells cells to build better mitochondria. SS-31 keeps existing ones from breaking down. NAD+ makes sure there's enough energy currency to power both.
The Three Axes of Mitochondrial Health
| Axis | Function | How It Fails | Result |
|---|---|---|---|
| Cardiolipin integrity | Anchors electron transport chain | Oxidized membranes leak electrons | Low ATP, high ROS, inflammation |
| Redox currency (NAD+) | Powers enzymes, activates sirtuins | Depleted by stress, aging, alcohol | Fatigue, DNA damage, metabolic rigidity |
| Adaptive signaling (AMPK → PGC-1α) | Drives mitochondrial biogenesis | Blunted by cortisol, nutrient overload | Slow recovery, weight gain |
Component 1: SS-31 — Membrane Repair
Every mitochondrion has an inner membrane where energy production happens. That membrane depends on a specific molecule — cardiolipin — to hold the energy-producing machinery in place. As cardiolipin degrades from age and oxidative stress, the machinery loosens. Energy output drops. Waste products (reactive oxygen species) spike. The mitochondrion starts costing more to run than it produces.
SS-31 (also called Elamipretide) stabilizes cardiolipin directly — tightening the energy-producing chain so it runs cleanly instead of leaking. Preclinical models show up to 60% reduction in oxidative waste. What you notice: more steady energy from each breath, less post-exertion fatigue, faster recovery from physical stress.
SS-31 has the most advanced clinical data of any mitochondrial peptide¹ — Phase 2 trials in Barth syndrome and cardiomyopathies confirmed improved energy production and functional outcomes.
See SS-31 guide for complete coverage.
Component 2: MOTS-c — Metabolic Reprogramming
Your body already makes MOTS-c — mitochondria release it during exercise. It's the signal that tells cells to adapt: build more mitochondria, get better at burning fat, improve how you handle glucose. Exercise increases circulating MOTS-c levels by up to 12-fold. The peptide mimics that signal directly.
Where SS-31 repairs the mitochondria you have, MOTS-c tells your body to build new ones. It activates the same metabolic switch as intense exercise (AMPK), triggering construction of fresh mitochondria and shifting cells from storing glucose to flexibly burning whatever fuel is available. Endurance improves. Metabolic rate stabilizes. The body responds better to caloric deficits instead of fighting them.
Published in Cell Metabolism (2015)² by the Cohen Lab at USC, with follow-up studies confirming metabolic benefits in humans.
See MOTS-c guide for more.
Component 3: NAD+ — Cellular Fuel
NAD+ is the energy currency that every cellular repair process runs on — DNA repair, inflammation control, the enzymes that regulate aging (sirtuins), and mitochondrial function itself. Your levels decline roughly 50% between age 20 and 50⁴, and faster under chronic stress or inflammation. When NAD+ drops, cells stop investing in repair and start triaging — maintaining minimum function instead of rebuilding.
Restoring NAD+ reactivates the repair enzymes that had gone quiet, calms the DNA-repair machinery that over-consumes resources when damaged, and helps resynchronize your circadian rhythm. What you notice: sustained energy through the day, better sleep quality, clearer thinking, deeper recovery between workouts.
Multiple human trials with NAD+ precursors (NMN, NR) confirm tissue levels can be restored.⁴ Injectable NAD+ provides higher peak levels than oral precursors.
See NAD+ Guide for a deep dive.
How the Components Work Together
Each compound addresses a different failure point, and each one's effectiveness depends on the others:
- SS-31 + NAD+: SS-31 tightens the energy-producing machinery. NAD+ provides the fuel it runs on. Without fuel, a repaired engine idles. Without a functioning engine, fuel has nowhere to go.
- MOTS-c + NAD+: MOTS-c builds new mitochondria. New mitochondria need NAD+ to function — building them without fueling them produces empty shells.
- SS-31 + MOTS-c: SS-31 repairs existing mitochondria while MOTS-c constructs new ones. Together, both the current fleet and the new additions work properly.
The inflection point: when ATP production exceeds the cell's maintenance cost, it stops triaging and starts investing. Collagen renews. Nerves fire cleanly. Hormones regain sensitivity. You feel it as a shift from "managing decline" to "actually recovering."
Protocol: 12-Week Mito Stack Cycle
| Phase | SS-31 | MOTS-c | NAD+ | Support |
|---|---|---|---|---|
| Weeks 1–2 (loading) | 10 mg daily × 5–7 days, then 3×/week | n/a | 200 mg 4-5×/week | Electrolytes, zone-2 cardio |
| Weeks 3–6 | 5-10 mg 3×/week | 5-10 mg 2×/week | 150–200 mg 3–5×/week | Resistance training, protein ≥1.6 g/kg |
| Weeks 7–12 | 5-10 mg 2–3×/week | 5–10 mg 2×/week | 100-150 mg 3–4×/week | Sleep 7–9 hours, glycine + collagen |
Cycling: 12 weeks on, 4 weeks off. Repeat twice yearly or maintain lighter cadence (SS-31 weekly, MOTS-c pulses, NAD+ 2–3×/week).
Need help preparing your peptides? See the Reconstitution Guide for step-by-step instructions.
Timeline of Effects
| Timeframe | Cellular changes | What you notice |
|---|---|---|
| Weeks 1–2 | SS-31 tightens ETC, ROS drops | Warm steady energy, less soreness |
| Weeks 3–4 | MOTS-c activates AMPK/PGC-1α | Cardio feels easier, cravings decrease |
| Weeks 5–8 | NAD+ + sirtuins repair DNA/membranes | Better sleep, clearer skin, mental sharpness |
| Weeks 9–12 | Mitochondrial density peaks | Resilience under stress, faster recovery |
Applications
GLP-1 Fatigue: The Mitochondrial Bottleneck
Fatigue is the most common complaint among people on GLP-1 medications. Semaglutide fatigue, tirzepatide fatigue, ozempic fatigue, mounjaro fatigue — different drug names, same pattern. Weight loss works, but energy crashes. The forums are full of people who hit a wall around month 2–3.
Why it happens: GLP-1 agonists shift metabolism rapidly toward fat oxidation. Fat burning is more mitochondrially demanding than glucose burning. When the instruction to increase oxidation arrives at mitochondria that were already running near capacity — because of age, chronic inflammation, or baseline depletion — they can't keep up. ATP production falters under the new demand.
Why the Mito Stack helps: The stack addresses all three failure points:
- SS-31 repairs the membrane structure so electrons flow cleanly (less waste, more output)
- MOTS-c signals cells to build more mitochondria and improve fuel selection (more capacity)
- NAD+ provides the redox currency both processes require (fuel for the machinery)
The result: mitochondria can actually execute what GLP-1s are asking for. Energy stabilizes, the "wall" retreats, and weight loss continues without the fatigue tax.
Practical integration: While not prescriptive, many practitioners begin the Mito Stack after 4–6 weeks of GLP-1 therapy, when fatigue becomes noticeable and blood plasma levels have stabilized. Starting MOTS-c at 5mg 2–3×/week and NAD+ support addresses the immediate bottleneck. SS-31 is added if fatigue persists or if recovery from exercise remains slow.
For a complete breakdown of why each GLP-1 compound causes different types of fatigue — and the full intervention hierarchy from protein to mitochondrial support — see Why GLP-1 Medications Make You Tired. For retatrutide-specific NAD+ implementation, see the Retatrutide + NAD+ Protocol.
Injury recovery
The Mito-Stack provides the ATP foundation that tissue repair requires. It's typically used after vascular restoration (BPC-157/TB-500) when cellular energy becomes the limiting factor (typically after four weeks). See our injury recovery protocol for more detail.
Longevity and anti-aging
By sustaining sirtuin activity, supporting DNA repair, and maintaining mitochondrial density, the Mito-Stack addresses the metabolic decline that underlies aging.
Side Effects and Safety
SS-31: FDA approved for Barth's Syndrome (at much higher doses). Generally well tolerated.
MOTS-c: Fatigue may present if caloric needs are not addressed, especially alongside GLP-1s. Eat adequately on training days.
NAD+: Slow injection rate to avoid flushing, dizziness. Hydration is important.
Contraindications: Active malignancy, uncontrolled hypertension, acute infection — pause until resolved.
Monitoring: Consider baseline and month-2 checks for CMP, lipids, and hs-CRP.
FAQ
Can I run the Mito Stack without NAD+ injections?
You'll blunt the synergy. NAD+ is the currency the other peptides spend. Oral NMN/NR is an alternative but provides lower peak levels than injection.
How does The Mito Stack differ from NAD+ therapy alone?
NAD+ provides fuel but doesn't repair damaged membranes (SS-31's role) or stimulate new mitochondrial construction (MOTS-c's role). The full Mito Stack addresses root causes — structure, signaling, and fuel — rather than currency alone.
Is the Mito Stack anabolic?
Not directly muscle-building, but by improving ATP production and reducing inflammation, it makes training and any growth-hormone protocol more effective.
What is the best MOTS-c and SS-31 stack dosage?
Most protocols use MOTS-c 5–10 mg and SS-31 8-10 mg, administered 2–3 times weekly. The Mito Stack adds NAD+ 150–200 mg to complete the triad. See the Protocol section above for phase-specific dosing.
Can I take MOTS-c and SS-31 together on the same day?
Yes, but separate them by 4-6 hours or use alternating days. SS-31 stabilizes mitochondrial membrane structure (a conservation signal), while MOTS-c drives AMPK-mediated biogenesis (an expansion signal). Administering both simultaneously sends opposing instructions to the same organelle. Morning SS-31 with afternoon MOTS-c — or alternating days — lets each signal resolve before the next arrives.
Related Topics
- NAD+ Guide — Complete NAD+ overview
- BPC-157 + TB-500 for Injury Recovery — Vascular restoration
- Retatrutide + NAD+ Protocol — GLP-1 with metabolic support
- SS-31 Guide — Elamipretide — Cardiolipin stabilizer at the core of the stack
- Peptide Stacking Guide — How the Mito Stack fits into the 5-axis stacking framework
- BPC-157 Guide — Vascular repair often needed before the Mito Stack is effective
- TB-500 Guide — Cellular mobility layer often preceding the Mito Stack
- Semaglutide Guide — GLP-1 agonist — The Mito Stack addresses its mitochondrial costs
- Tirzepatide Guide — Dual-agonist — The Mito Stack supports during therapy
- Circadian Reset Protocol — How NAD+/MOTS-c support the circadian clock through the SIRT1-CLOCK/BMAL1 axis
References
SS-31 (Elamipretide)
¹ Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. doi:10.1111/bph.12461
² Phase 2 trials in Barth syndrome and cardiomyopathies demonstrate improved ATP kinetics and functional endpoints
MOTS-c
³ Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009
⁴ Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression. Cell Metab. 2018;28(3):516-524. doi:10.1016/j.cmet.2018.06.008
NAD+
⁵ Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011
- Multiple RCTs with NMN/NR precursors demonstrate tissue NAD+ elevation and functional improvements
Medical Disclaimer
The content in this protocol guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before beginning any new protocol, supplement, or medication.